Kura Oncology (KURA) News Today $7.86 +0.47 (+6.36%) As of 01/22/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Cantor Fitzgerald Forecasts Kura Oncology FY2025 EarningsJanuary 23 at 2:11 AM | americanbankingnews.comCantor Fitzgerald Weighs in on Kura Oncology FY2025 EarningsKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for Kura Oncology in a research note issued on Tuesday, January 21st. Cantor Fitzgerald analyst L. Watsek forecasts that the company will earn ($2.94) per share for theJanuary 22 at 6:49 AM | marketbeat.comAssenagon Asset Management S.A. Sells 146,879 Shares of Kura Oncology, Inc. (NASDAQ:KURA)Assenagon Asset Management S.A. decreased its holdings in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 14.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 905,184 shares of the company's stock after seJanuary 20 at 3:22 AM | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Sees Large Growth in Short InterestKura Oncology, Inc. (NASDAQ:KURA - Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 10,440,000 shares, an increase of 17.4% from the December 15th total of 8,890,000 shares. Approximately 16.0% of the company's shares are sold short. Based on an average trading volume of 1,660,000 shares, the days-to-cover ratio is currently 6.3 days.January 19, 2025 | marketbeat.comKura Oncology Signs Lease Agreement for New Executive OfficesJanuary 16, 2025 | americanbankingnews.comKura Oncology (NASDAQ:KURA) Hits New 52-Week Low - What's Next?Kura Oncology (NASDAQ:KURA) Sets New 1-Year Low - Here's What HappenedJanuary 13, 2025 | marketbeat.comBrookline Capital Management Predicts Kura Oncology FY2029 EarningsKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities research analysts at Brookline Capital Management issued their FY2029 earnings estimates for Kura Oncology in a report issued on Monday, January 6th. Brookline Capital Management analyst L. Cann anticipates that the company will earn $12.January 9, 2025 | marketbeat.comKura Oncology price target lowered to $10 from $18 at ScotiabankJanuary 8, 2025 | markets.businessinsider.comKura Oncology (NASDAQ:KURA) Price Target Cut to $10.00 by Analysts at ScotiabankScotiabank lowered their price target on Kura Oncology from $18.00 to $10.00 and set a "sector perform" rating on the stock in a research report on Wednesday.January 8, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Sets New 1-Year Low - Time to Sell?Kura Oncology (NASDAQ:KURA) Sets New 52-Week Low - What's Next?January 7, 2025 | marketbeat.comKura Oncology Promotes New Chief Medical OfficerJanuary 7, 2025 | marketwatch.comKura Oncology Announces Leadership Changes and AppointmentsJanuary 7, 2025 | msn.comKura Oncology Announces Senior Executive PromotionsJanuary 6, 2025 | globenewswire.comKura Oncology (NASDAQ:KURA) Reaches New 12-Month Low - What's Next?Kura Oncology (NASDAQ:KURA) Sets New 1-Year Low - Time to Sell?December 30, 2024 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Given Average Recommendation of "Buy" by AnalystsKura Oncology, Inc. (NASDAQ:KURA - Get Free Report) has received a consensus rating of "Buy" from the ten research firms that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating, eight have given a buy rating and one hasDecember 30, 2024 | marketbeat.comKura Oncology (NASDAQ:KURA) Reaches New 52-Week Low - What's Next?Kura Oncology (NASDAQ:KURA) Hits New 1-Year Low - Here's What HappenedDecember 18, 2024 | marketbeat.comKura Oncology Presents Deep Value At Today's Prices (Rating Upgrade)December 18, 2024 | seekingalpha.comKura Oncology’s Promising Clinical Advances and Strategic Pipeline Developments Justify Buy RatingDecember 11, 2024 | markets.businessinsider.comJonathan Chang Recommends ‘Buy’ on Kura Oncology Amid Promising Ziftomenib Advancements in AML TreatmentDecember 10, 2024 | markets.businessinsider.comBuy Rating Affirmed for Kura Oncology Amid Promising Trial ResultsDecember 10, 2024 | markets.businessinsider.comJefferies Reaffirms Their Buy Rating on Kura Oncology (KURA)December 9, 2024 | markets.businessinsider.comPromising Clinical Trial Developments in Kura Oncology’s Ziftomenib for AML TreatmentDecember 9, 2024 | markets.businessinsider.comKura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual MeetingDecember 9, 2024 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX) and Kura Oncology (KURA)December 8, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Kura Oncology (KURA), Cooper Co (COO) and Ironwood Pharma (IRWD)December 6, 2024 | markets.businessinsider.comKura Oncology management to meet with Cantor FitzgeraldDecember 5, 2024 | markets.businessinsider.comWhy Is Kura Oncology, Inc. (KURA) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?December 5, 2024 | msn.comKura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Recommendation of "Buy" from BrokeragesKura Oncology, Inc. (NASDAQ:KURA - Get Free Report) has been assigned a consensus rating of "Buy" from the eleven brokerages that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold rating, nine have assigned a buy rating and one has given a stronDecember 5, 2024 | marketbeat.comJefferies Sticks to Its Buy Rating for Kura Oncology (KURA)December 2, 2024 | markets.businessinsider.comKura Oncology to Host Virtual Investor Event on December 9, 2024December 2, 2024 | globenewswire.comPharma giant Roche to buy San Diego biotech for up to $1.5BDecember 1, 2024 | msn.comStifel Nicolaus Keeps Their Hold Rating on Kura Oncology (KURA)November 26, 2024 | markets.businessinsider.comKura Oncology to Participate in JMP Securities Hematology and Oncology SummitNovember 25, 2024 | globenewswire.comFY2025 EPS Estimate for Kura Oncology Raised by AnalystKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities research analysts at Brookline Capital Management boosted their FY2025 earnings per share (EPS) estimates for Kura Oncology in a research report issued to clients and investors on Thursday, November 21st. Brookline Capital Management analNovember 25, 2024 | marketbeat.comLeerink Partnrs Expects Higher Earnings for Kura OncologyKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Stock analysts at Leerink Partnrs increased their FY2024 earnings per share estimates for shares of Kura Oncology in a research report issued to clients and investors on Thursday, November 21st. Leerink Partnrs analyst J. Chang now forecasts thatNovember 25, 2024 | marketbeat.comKura Oncology (KURA) Gets a Hold from ScotiabankNovember 23, 2024 | markets.businessinsider.comKura Oncology, Inc. (KURA): Among the Most Promising Cancer Stocks According to Hedge FundsNovember 23, 2024 | insidermonkey.comKura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26%November 22, 2024 | msn.comKura Oncology’s Strategic Developments and Partnership with Kyowa Kirin Justify Buy Rating, Despite Initial Stock DipNovember 22, 2024 | markets.businessinsider.comBofA lowers Kura Oncology price target to $29, sees buying opportunityNovember 22, 2024 | markets.businessinsider.comKura Oncology (NASDAQ:KURA) Sees Strong Trading Volume on Analyst UpgradeKura Oncology (NASDAQ:KURA) Sees Unusually-High Trading Volume After Analyst UpgradeNovember 22, 2024 | marketbeat.comBank of America Has Lowered Expectations for Kura Oncology (NASDAQ:KURA) Stock PriceBank of America lowered their price target on shares of Kura Oncology from $36.00 to $29.00 and set a "buy" rating on the stock in a report on Friday.November 22, 2024 | marketbeat.comKura selling off on loss of acquisition premium, says TD CowenNovember 22, 2024 | markets.businessinsider.comKura Oncology (KURA) Gets a Hold from Stifel NicolausNovember 22, 2024 | markets.businessinsider.comKura Oncology (KURA) Gets a Hold from Stifel NicolausNovember 22, 2024 | markets.businessinsider.comKura Oncology price target lowered to $34 from $37 at WedbushNovember 22, 2024 | markets.businessinsider.comKura Oncology price target lowered to $34 from $37 at WedbushNovember 22, 2024 | markets.businessinsider.comKura Oncology: A Contender In The Field Of Precision MedicineNovember 22, 2024 | seekingalpha.comKura Crashes 37% After $1.53 Billion Deal Slams The Door On A TakeoverNovember 22, 2024 | msn.comKura Oncology Stock Slips Following Collaboration With Kyowa: Retail Turns Extremely BullishNovember 21, 2024 | msn.com Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address KURA Media Mentions By Week KURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KURA News Sentiment▼1.040.64▲Average Medical News Sentiment KURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KURA Articles This Week▼56▲KURA Articles Average Week Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MIRM News HRMY News CGON News PTGX News NAMS News JANX News VERA News IBRX News CNTA News MESO News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KURA) was last updated on 1/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kura Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kura Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KURA Stock Alerts